234 related articles for article (PubMed ID: 24124606)
21. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.
Brandal LT; Vestrheim DF; Bruvik T; Roness RB; Bjørnstad ML; Greve-Isdahl M; Steens A; Brynildsrud OB
Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):913-924. PubMed ID: 35543837
[TBL] [Abstract][Full Text] [Related]
22. Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
Schmidtke AJ; Boney KO; Martin SW; Skoff TH; Tondella ML; Tatti KM
Emerg Infect Dis; 2012 Aug; 18(8):1248-55. PubMed ID: 22841154
[TBL] [Abstract][Full Text] [Related]
23. Severe pertussis infection in infants less than 6 months of age: Clinical manifestations and molecular characterization.
Stefanelli P; Buttinelli G; Vacca P; Tozzi AE; Midulla F; Carsetti R; Fedele G; Villani A; Concato C;
Hum Vaccin Immunother; 2017 May; 13(5):1073-1077. PubMed ID: 28129036
[TBL] [Abstract][Full Text] [Related]
24. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
[TBL] [Abstract][Full Text] [Related]
25. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
26. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.
Borisova O; Kombarova SY; Zakharova NS; van Gent M; Aleshkin VA; Mazurova I; Mooi FR
Clin Vaccine Immunol; 2007 Mar; 14(3):234-8. PubMed ID: 17202309
[TBL] [Abstract][Full Text] [Related]
27. Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016.
Ben Fraj I; Kechrid A; Guillot S; Bouchez V; Brisse S; Guiso N; Smaoui H
J Med Microbiol; 2019 Feb; 68(2):241-247. PubMed ID: 30526740
[TBL] [Abstract][Full Text] [Related]
28. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
Bailon H; León-Janampa N; Padilla C; Hozbor D
BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
[TBL] [Abstract][Full Text] [Related]
29. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
30. Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
Yang Y; Yao K; Ma X; Shi W; Yuan L; Yang Y
PLoS One; 2015; 10(9):e0138941. PubMed ID: 26406905
[TBL] [Abstract][Full Text] [Related]
31. Resurgence of Pertussis and Emergence of the Ptxp3 Toxin Promoter Allele in South Italy.
Loconsole D; De Robertis AL; Morea A; Metallo A; Lopalco PL; Chironna M
Pediatr Infect Dis J; 2018 May; 37(5):e126-e131. PubMed ID: 28945679
[TBL] [Abstract][Full Text] [Related]
32. A Cross-Sectional Study Revealing the Emergence of Erythromycin-Resistant
Wu X; Du Q; Li D; Yuan L; Meng Q; Fu Z; Xu H; Yao K; Zhao R
Front Microbiol; 2022; 13():901617. PubMed ID: 35923401
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.
van Gent M; Heuvelman CJ; van der Heide HG; Hallander HO; Advani A; Guiso N; Wirsing von Kőnig CH; Vestrheim DF; Dalby T; Fry NK; Pierard D; Detemmerman L; Zavadilova J; Fabianova K; Logan C; Habington A; Byrne M; Lutyńska A; Mosiej E; Pelaz C; Gröndahl-Yli-Hannuksela K; Barkoff AM; Mertsola J; Economopoulou A; He Q; Mooi FR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):821-30. PubMed ID: 25527446
[TBL] [Abstract][Full Text] [Related]
34. Multilocus sequence typing of Bordetella pertussis based on surface protein genes.
van Loo IH; Heuvelman KJ; King AJ; Mooi FR
J Clin Microbiol; 2002 Jun; 40(6):1994-2001. PubMed ID: 12037054
[TBL] [Abstract][Full Text] [Related]
35. Genomic characterization of
Moosa F; du Plessis M; Weigand MR; Peng Y; Mogale D; de Gouveia L; Nunes MC; Madhi SA; Zar HJ; Reubenson G; Ismail A; Tondella ML; Cohen C; Walaza S; von Gottberg A; Wolter N
Microb Genom; 2023 Dec; 9(12):. PubMed ID: 38117675
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.
Otsuka N; Han HJ; Toyoizumi-Ajisaka H; Nakamura Y; Arakawa Y; Shibayama K; Kamachi K
PLoS One; 2012; 7(2):e31985. PubMed ID: 22348138
[TBL] [Abstract][Full Text] [Related]
37. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
38. Genotypes of
Zhang J; Lin C; Chang L; Wang X; Wei X; Li H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):47-52. PubMed ID: 35462464
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
40. Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in China.
Fu P; Zhou J; Meng J; Liu Z; Nijiati Y; He L; Li C; Chen S; Wang A; Yan G; Lu G; Zhou L; Zhai X; Wang C
Int J Infect Dis; 2023 Mar; 128():205-211. PubMed ID: 36632892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
